Time trend in tumour size and characteristics of anaplastic thyroid carcinoma

Clinical Endocrinology

Volumn 77, Issue 3, 2012, Pages 459-464

  Han, Ji Min ^a   Kim, Won Bae ^a   Kim, Tae Yong ^a   Ryu, Jin Sook ^a   Gong, Gyungyub ^a   Hong, Suck Joon ^a   Kim, Jung Han ^b   Oh, Young Lyun ^b   Jang, Hye Won ^b   Kim, Sun Wook ^b   Chung, Jae Hoon ^b   Shong, Young Kee ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MORBIDITY; PRIORITY JOURNAL; THYROID CARCINOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL DIFFERENTIATION; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; YOUNG ADULT;

EID: 84864975905     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04396.x     Document Type: Article

References (16)

1. Ain, K.B., (1998) Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid, 8, 715-726.
2. Giuffrida, D., &, Gharib, H., (2000) Anaplastic thyroid carcinoma: current diagnosis and treatment. Annals of Oncology, 11, 1083-1089.
3. Pasieka, J.L., (2003) Anaplastic thyroid cancer. Current Opinion in Oncology, 15, 78-83.
4. Besic, N., Auersperg, M., Us-Krasovec, M., et al,. (2001) Effect of primary treatment on survival in anaplastic thyroid carcinoma. European Journal of Surgical Oncology, 27, 260-264.
5. Kebebew, E., Greenspan, F.S., Clark, O.H., et al,. (2005) Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer, 103, 1330-1335.
6. McIver, B., Hay, I.D., Giuffrida, D.F., et al,. (2001) Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery, 130, 1028-1034.
7. Nilsson, O., Lindeberg, J., Zedenius, J., et al,. (1998) Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World Journal of Surgery, 22, 725-730.
8. Davies, L., &, Welch, H.G., (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA: The Journal of the American Medical Association, 295, 2164-2167.
9. Spires, J.R., Schwartz, M.R., &, Miller, R.H., (1988) Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer. Archives of Otolaryngology-Head and Neck Surgery, 114, 40-44.
10. Venkatesh, Y.S., Ordonez, N.G., Schultz, P.N., et al,. (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer, 66, 321-330.
11. Kim, T.Y., Kim, K.W., Jung, T.S., et al,. (2007) Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head and Neck, 29, 765-772.
12. Sugitani, I., Kasai, N., Fujimoto, Y., et al,. (2001) Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World Journal of Surgery, 25, 617-622.
13. Rego-Iraeta, A., Perez-Mendez, L.F., Mantinan, B., et al,. (2009) Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid, 19, 333-340.
14. Trimboli, P., Ulisse, S., Graziano, F.M., et al,. (2006) Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid, 16, 1151-1155.
15. Akaishi, J., Sugino, K., Kitagawa, W., Nagahama, M., Kameyama, K., Shimizu, K., &, Ito, K., (2011) Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid, 21, 1183-1189.
16. Haigh, P.I., Ituarte, P.H., Wu, H.S., et al,. (2001) Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer, 91, 2335-2342.